{"nctId":"NCT00492557","briefTitle":"Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults","startDateStruct":{"date":"2007-09"},"conditions":["Pneumococcal Infections"],"count":1185,"armGroups":[{"label":"13vPnC+TIV Followed by Placebo 1 month later","type":"EXPERIMENTAL","interventionNames":["Biological: 13-valent pneumococcal conjugate vaccine"]},{"label":"Placebo+TIV Followed by 13vPnC 1 month later","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: 13vPnC + TIV"]}],"interventions":[{"name":"13-valent pneumococcal conjugate vaccine","otherNames":[]},{"name":"13vPnC + TIV","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Generally healthy male or female adults 65 years of age or older.\n* Available for the duration of the trial - approximately 2 months.\n* No previous vaccination with any pneumococcal vaccine.\n* No history of severe adverse reaction associated with a vaccine.\n* No allergy to egg proteins (eggs or egg products) and chicken proteins.","healthyVolunteers":true,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"TIV Comparisons: Percentage of Participants Achieving at Least a 4-fold Increase in the Titer of the Standard Hemagglutination Inhibition Assay (HAI)","description":"Percentage of participants achieving at least a 4-fold increase in the titer of the standard HAI for each influenza virus subtype (A/H1N1, A/H3N2, and B) were compared.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80.3","spread":null},{"groupId":"OG001","value":"78.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.0","spread":null},{"groupId":"OG001","value":"62.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.2","spread":null},{"groupId":"OG001","value":"54.0","spread":null}]}]}]},{"type":"PRIMARY","title":"13vPnC Comparisons: Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMC)","description":"IgG GMC as measured by enzyme-linked immunosorbent assay (ELISA) and expressed in micrograms per mL (mcg/mL) for serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":null},{"groupId":"OG001","value":"3.20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.08","spread":null},{"groupId":"OG001","value":"1.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.15","spread":null},{"groupId":"OG001","value":"3.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.74","spread":null},{"groupId":"OG001","value":"6.90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.61","spread":null},{"groupId":"OG001","value":"6.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.24","spread":null},{"groupId":"OG001","value":"6.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.63","spread":null},{"groupId":"OG001","value":"9.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.97","spread":null},{"groupId":"OG001","value":"6.21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.95","spread":null},{"groupId":"OG001","value":"12.44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.88","spread":null},{"groupId":"OG001","value":"11.07","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.93","spread":null},{"groupId":"OG001","value":"17.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.78","spread":null},{"groupId":"OG001","value":"7.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.82","spread":null},{"groupId":"OG001","value":"6.11","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants With Pre-specified Local Reactions","description":"Local reactions were reported using an electronic diary. Pain was scaled as Any; Mild (awareness but easily tolerated); Moderate (discomfort enough to interfere with usual activity) and Severe (incapacitating the usual activity). Redness and swelling were scaled as Any; Mild (2.5 cm to 5.0 cm); Moderate (5.1 to 10.0 cm)and Severe (\\> 10.0 cm). Limitation in arm movement were scaled as Any; Mild (some limitation); Moderate (unable to move above head but able to move above shoulder) and Severe (unable to move above shoulder).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.6","spread":null},{"groupId":"OG001","value":"12.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.4","spread":null},{"groupId":"OG001","value":"9.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":null},{"groupId":"OG001","value":"6.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":null},{"groupId":"OG001","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.8","spread":null},{"groupId":"OG001","value":"10.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.8","spread":null},{"groupId":"OG001","value":"8.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.0","spread":null},{"groupId":"OG001","value":"43.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.3","spread":null},{"groupId":"OG001","value":"37.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.8","spread":null},{"groupId":"OG001","value":"19.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"2.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.9","spread":null},{"groupId":"OG001","value":"14.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.1","spread":null},{"groupId":"OG001","value":"13.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":null},{"groupId":"OG001","value":"1.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9","spread":null},{"groupId":"OG001","value":"46.6","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants With Pre-specified Systemic Events","description":"Systemic events (Any fever \\>= 38 degrees Celsius \\[C\\]), fatigue, headache, chills, rash, vomiting, decreased appetite, new muscle pain, any aggravated muscle pain, new joint pain or any aggravated joint pain. Participants may be presented in more than one category.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null},{"groupId":"OG001","value":"3.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"0.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.4","spread":null},{"groupId":"OG001","value":"28.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.6","spread":null},{"groupId":"OG001","value":"24.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.8","spread":null},{"groupId":"OG001","value":"9.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.9","spread":null},{"groupId":"OG001","value":"6.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null},{"groupId":"OG001","value":"1.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.9","spread":null},{"groupId":"OG001","value":"11.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.9","spread":null},{"groupId":"OG001","value":"23.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.7","spread":null},{"groupId":"OG001","value":"15.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.2","spread":null},{"groupId":"OG001","value":"11.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":null},{"groupId":"OG001","value":"8.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.2","spread":null},{"groupId":"OG001","value":"48.6","spread":null}]}]}]},{"type":"POST_HOC","title":"13vPnC Comparisons: Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMT)","description":"Pneumococcal OPA GMTs for 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of a subset of participants using a microcolony OPA (mcOPA) assay.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null},{"groupId":"OG001","value":"95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"997","spread":null},{"groupId":"OG001","value":"1486","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"112","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1220","spread":null},{"groupId":"OG001","value":"1597","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1564","spread":null},{"groupId":"OG001","value":"2017","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"607","spread":null},{"groupId":"OG001","value":"835","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"477","spread":null},{"groupId":"OG001","value":"723","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"975","spread":null},{"groupId":"OG001","value":"1088","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1158","spread":null},{"groupId":"OG001","value":"1415","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"445","spread":null},{"groupId":"OG001","value":"539","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"378","spread":null},{"groupId":"OG001","value":"467","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"245","spread":null},{"groupId":"OG001","value":"295","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":576},"commonTop":["Fatigue","Headache","Pain (any)","Pain (mild)","New muscle pain"]}}}